Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-17

Clinical Trial Update: Combination Therapy in Pulmonary Arterial Hypertension [Phase 4]

View source ↗

Summary

Actelion-sponsored Phase 4 trial evaluating a combination therapy for pulmonary arterial hypertension has completed, with results posted in May 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2013-05-17